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Abstract Prediction of 3D structures of membrane pro-
teins, and of G-protein coupled receptors (GPCRs) in
particular, is motivated by their importance in biological
systems and the difficulties associated with experimental
structure determination. In the present study, a novel
method for the prediction of 3D structures of the mem-
brane-embedded region of helical membrane proteins is
presented. A large pool of candidate models are produced
by repacking of the helices of a homology model using
Monte Carlo sampling in torsion space, followed by
ranking based on their geometric and ligand-binding
properties. The trajectory is directed by weak initial
restraints to orient helices towards the original model to
improve computation efficiency, and by a ligand to guide
the receptor towards a chosen conformational state. The
method was validated by construction of the b1 adrenergic
receptor model in complex with (S)-cyanopindolol using
bovine rhodopsin as template. In addition, models of the
dopamine D2 receptor were produced with the selective
and rigid agonist (R)-N-propylapomorphine ((R)-NPA)
present. A second quality assessment was implemented by
evaluating the results from docking of a library of 29
ligands with known activity, which further discriminated
between receptor models. Agonist binding and recognition
by the dopamine D2 receptor is interpreted using the 3D
structure model resulting from the approach. This method
has a potential for modeling of all types of helical trans-
membrane proteins for which a structural template with
sequence homology sufficient for homology modeling is
not available or is in an incorrect conformational state, but
for which sufficient empirical information is accessible.
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TM Transmembrane
TM1, …, TM7 Transmembrane helix 1, …, 7
VLS Virtual ligand screening
Introduction
The family of monoaminergic G-protein coupled receptors
(GPCRs) is well-studied due to their relevance as drug
targets. For a complete understanding of the detailed
mechanism for ligand interaction with these receptors,
access to accurate and reliable 3D structures is needed.
GPCRs are believed to exist in active signaling states sta-
bilized by agonists, and in inactive states stabilized by
inverse agonists [1, 2]. The high affinity state has been
shown to be associated with the functional state of the
receptor which activates the G-protein and induces down-
stream signaling [1, 3]. Solved 3D structures of GPCRs
include several structures of rhodopsin with (e.g. Refs. [4,
5]) and without (e.g. Refs. [6, 7]) covalently bound trans-
retinal, the inactive states of the turkey b1- [8] and human
b2- [9, 10] adrenergic receptors (b1AR and b2AR), the
human A2A adenosine receptor with a bound inverse ago-
nist [11], and the CXCR chemokine receptor [12] and
dopamine D3 receptor with an antagonist [13]. For a recent
review on all GPCRs of known structures, see Reference
[14]. Only recently have structures of active- or near-
active-state GPCRs in the presence of agonists been
determined, achieved using an A2A adenosine receptor—
T4L chimera bound to UK432097 [15], thermostabilized
A2A adenosine receptors bound to adenosine and NECA
[16], or by using fragments of antibodies to stabilize the
agonist-bound state of the b2AR [17, 18]. These structures
confirmed previous hypotheses [19–22] that the agonist-
bound active-state binding site is contracted by 1–2 A˚
relative to that bound to structurally related inverse ago-
nists. The major conformational changes, however, occur
on the intracellular side where transmembrane helices 5
and 6 (TM5 and 6) are extended and move outwards to
allow binding of the G-protein.
Although several examples of family A GPCR struc-
tures have recently appeared in the literature, their exper-
imental structure determination is time-consuming and
difficult, which makes access to modeling techniques
highly desirable. A protein structure in a particular con-
formational state can be used to predict the structure of
another protein of sufficient sequence homology in that
same state using homology modeling. Three-dimensional
models that can identify antagonists in virtual ligand
screening (VLS) experiments have been constructed by
inclusion of QSAR data [23], and new micromolar
antagonists have been discovered based on VLS using a
structure model where binding pocket side chains were
optimized with a ligand present [24] or by repacking of the
transmembrane part [25]. Tang et al. [26] reported that
manually refined homology models may be on par or even
better than crystal structures for VLS. For the majority of
GPCRs, however, the sequence identity within the family
is generally low [27], and only few structures of GPCRs in
an active, agonist-bound state have been reported. In
addition, the structural diversity of solved GPCR struc-
tures, mainly in loop regions and at the intracellular side,
shows that homology modeling of remote homologs will be
challenging. An additional complication is that GPCRs
bind ligands through multiple conformational states.
Therefore, the inactive-state crystal structure of the b2
adrenergic receptor (b2AR) was not able to represent the
interactions with agonists [19], and the identification of
agonists by VLS using homology models based on inac-
tive-state structures was only possible after careful struc-
tural refinement (see e.g. refs. [21, 28, 29]).
Methods for ab initio prediction of receptor structure aim to
circumvent the problem of lack of closely related template
structures. Transmembrane helices are constructed from the
amino acid sequence, followed by their assembly into a helix
bundle guided by data from known structures. Several
approaches have been described: Yarov-Yarovoy et al. [30]
adapted the ROSETTA structure prediction method for mem-
brane proteins, and applied it to 12 diverse membrane proteins.
Goddard and coworkers developed MembStruk and applied it
to the prostaglandin D [31], b2AR [32] and dopamine D2 [33]
(D2R) receptors. Shacham et al. [34] developed the PREDICT
approach to model the D2R, the neurokinin NK1 and neuro-
peptide Y1 receptors. Other studies describe methods where
homology models are modified in a systematic way to over-
come the lack of appropriate templates. For example, Evers and
Klebe [23] reported an iterative homology model building
method including ligand restraints which was used to produce
an NK1 receptor model that allowed the identification of a
compound that inhibited substance P binding. Michino et al.
[35] recently reported a method that reproduced the rhodopsin
and b2AR/carazolol structures to approximately 2–2.5 A˚ Ca
RMSD by restrained molecular dynamics simulation of the
helical regions. We have previously modeled dopamine D2 [36]
and D1 [37] receptors using homology modeling with an ago-
nist present in the binding site during the procedure. The model
RMSD for Ca in the TM region relative to the template structure
(b2AR, pdb code 2rh1 [19]) was 1.9 A˚ and 1.5 A˚ for the D1 and
D2 receptor models, respectively.
We present here a new method to generate all-atom
models of the membrane-spanning part of TM proteins that
repacks secondary structure elements of a homology model
guided by a ligand and a limited set of experimental and
evolutionary restraints. The rationale is to allow models to
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deviate more from the template structure than homology
modeling does, while including experimental restraints
based on other experimental data in order to make the
conformational search efficient. An initial homology model
is subjected to random helix displacements and Monte
Carlo geometry optimization to generate a large number of
receptor conformations from which the most probable
candidates are selected by means of a scoring scheme. The
method contains several elements of ab inito protein
structure modeling, but also uses restraints of experimental
origin, and is therefore referred to as a semi-empirical
approach. An agonist was present in the binding site during
the modeling to focus sampling towards the agonist-bound
conformation. The main goal of the current study was to
analyze ligand binding to the D2R binding site, and
therefore selected models were further evaluated by
docking of 29 compounds with known pharmacological
profiles towards the D2R.
Results and discussion
Helix docking method
In the present study, the receptor structure prediction was
based on the docking of seven individual helices (TM1–7)
that were initially rigid but gradually made more flexible as
structures became more refined. A homology model of the
transmembrane helices was used as the starting model,
numerous copies were created and their helix coordinates
were perturbed according to a defined stochastic scheme to
expand the covered conformational space, and brought
back to a compact shape by a Monte Carlo geometry
optimization (see below for details). A ligand was present
during the helix packing optimization to direct the bundle
towards a biologically relevant structural state, for example
agonist or inverse agonist-induced states.
Intra- and extracellular loops were removed to make the
conformational sampling more efficient, and also because
loops are notoriously difficult to predict as they vary both
in length and sequence [38]. The loops can be added back
to the helical bundle once the preferred solution (or solu-
tions) has been found. Although the second extracellular
loop is crucial for ligand discrimination in some receptors,
e.g. D2R [39–41], the present study focuses on the TM
region which contributes the majority of ligand contacts. In
addition, incorrect modeling of loops may have an adverse
effect on the results. Removal of loops in the b2AR
structure did not prevent the correct docking of carazolol
[27], and it has been shown that ligand docking has in fact
given equal or better results with the loops excluded [42].
The procedure is described in general terms below,
followed by a description of the scoring method, the
validation of the method by building of the b1AR, and
finally an application of the method to the D2R. A multiple
sequence alignment of relevant sequences was performed,
followed by manual editing guided by the 3D structures.
Typically, the modeling template (or templates) would be
chosen based on multiple factors, including the quality of
the pairwise alignments, the conformational state and
quality of the structures, and the structure of the ligand.
Structures of monoaminergic receptors are available for
modeling the D2R. However, we wanted to evaluate the
prediction method based on a more remote homolog, and
therefore chose bovine rhodopsin as template. The starting
structure was created from the helical regions of the tem-
plate structure using the modeling software ICM (ICM v
3.4, Molsoft LLC, CA), where the exact sequence positions
of helix termini were assessed manually to take sequence
alignments and 3D-structure into account.
In order to decrease the dependence on the template
model and cover a larger conformational space, many
copies of the helix bundles were made and each was
expanded and randomly displaced, i.e. each helix of a
model was moved by a random distance (0–5 A˚) away
from the bundle center in the membrane plane, tilted with
respect to its center (0 ± 20 ) and rotated around the
helical axis (0 ± 30 ). These values were derived by
observing the effects of different settings, and were found
to allow a proper sampling of the conformational space
while avoiding the generation of unrealistic starting struc-
tures. The molecular system was defined in internal coor-
dinate space which conveniently allows each of these
geometrical properties of a helix to be controlled by a
single variable (Fig. 1).
A ligand was placed at least 5 A˚ away from the helix
bundle and its positional and internal torsion variables were
randomized to ensure that the model was not biased
towards the starting geometry and position of the ligand.
Rigidity of the ligand reduces the risk that less realistic
complex models are generated due to incorrect ligand
geometry. A minimal number of loose distance restraints
were used to orient the ligand relative to amino acids that
are known to be important for ligand binding in the initial
optimization phases, as described in detail for each target
below. The purpose was to exclude docking conformations
that disagree with available data and generally accepted
concepts of receptor-ligand interactions.
Monte Carlo geometry optimization brought the bundle
back to a compact shape in four main stages. The first stage
was a rough optimization of rigid helices and rigid ligand,
followed by three optimization stages with increasing level
of detail and demand for computation resources (Fig. 2).
The main changes of the procedure during the process were
the following: (1) The number of free variables was
increased stepwise. Sets of torsion angles were gradually
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made flexible such that the final optimization was per-
formed over all torsion variables, including those of the
backbone. (2) Regions of high sequence conservation were
expected to be more structurally conserved, and the opti-
mization was therefore biased towards the starting structure
by the use of distance restraints to the homology model
(tethers) for strictly conserved residues with a target value
of 0 A˚. The strength of the tethers can be tuned such that
computational resources are not spent on sparsely packed
solutions (too weak restraints) while avoiding the regen-
eration of the starting structure (too strong restraints).
Tethers were gradually softened and completely turned off
during the longest, final optimization stage. (3) van der
Waals interactions were soft in the initial phase to decrease
steric repulsion energies of the coarse models and
increased gradually to standard Lennard-Jones 6–12
potentials.
We noticed that models that were geometrically unac-
ceptable at an early stage rarely resulted in satisfactory
models at the final stage. A scoring method (see the
‘‘Methods/experimental’’ section) was therefore developed
that evaluated the geometry of each model after stage 1 and
3. To probe how the scores varied as a function of simu-
lation time, intermediate geometries of a limited number of
structure models were evaluated during the optimization
stages (Supplementary Fig. 1). It was concluded that the
majority of the final high-scoring models were recovered
even if 50 % of the models were discarded earlier during
the optimization. By choosing proper score thresholds,
models are eliminated after the first and third stage which
dramatically improves performance since the later stages
are the most computationally intensive. The homology
model geometry perturbation and first optimization stage
are fast, and the first threshold is therefore set at a high
score value to produce a large pool of conformations to be
evaluated. When a selected number of final models are
available at the second threshold, the models are submitted
to the final fourth stage optimization.
The total number of models that are created depends on
the selected thresholds and on the selected number of final
models. For the complexes in this study, hundreds of
models were typically produced after rigid docking of
helices with ligand present (stage 1, Fig. 2), dozens at the
second and third stage, and around 10 models selected for
the final optimization.
Fig. 1 The overall position and orientation of a helix is determined
by six variables in the internal coordinate space representation, which
simplifies molecular transformations (e.g. controlled randomization of
helix positions) and makes geometry optimizations more efficient
[62]. Labels indicate the N-terminus (N), the center of mass of the
helix (M), the coordinate system axes (x, y, z) and virtual variables
(a1, b1, t1, a2, t2, t3)
Fig. 2 Overview of the generation of ligand-receptor models from a
homology model. The iterative process in A is increasingly CPU
demanding, allowing gradually more degrees of freedom, stronger
van der Waals interactions, and a decreased number of restraints.
Therefore, the results are scored at two stages so non-productive
solutions can be dismissed at early stages. In B, a library of
compounds is docked to the ten receptor models from A using the
standard ICM protocol. The model(s) that best matches binding data
is selected for analysis
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Generation of b1AR models from rhodopsin
The turkey b1AR receptor structure [8] in complex with
(S)-cyanopindolol was used to assess the structure predic-
tion method. A homology model was built based on the
2.2 A˚ resolution crystal structure of bovine rhodopsin
bound to the inverse agonist cis-retinal (pdb ID 1u19 [5]),
and the inverse agonist (S)-cyanopindolol in its protonated
form was generated from 2D coordinates and added to the
receptor model, using ICM. Two (S)-cyanopindolol atoms
were restrained to receptor residues to ensure the correct
length-wise orientation while avoiding the bias for the
exact local geometry (Fig. 3). The aim was to apply the
method to the D2R, and therefore the restraints were
selected to mimic those of the D2R case to ensure that the
results were comparable. Thus, the source of the restraints
was based on D2R experimental data, as described below.
A total number of 364 models were generated: 270
(stage 1), 42 (stages 2 and 3), and 10 (stage 4). The RMSDs
for Ca atoms of the models compared to the known b1AR
receptor structure (chain A of PDB ID 2vt4, Warne et al.
[8]) was between 2 and 6 A˚ for 92 % of the solutions
(Supplementary Fig. 2), and from 2.4 to 5.5 A˚ for the ten
stage 4 solutions (Supplementary Table 1). The corre-
sponding RMSD of the homology model was 2.9 A˚. Three
out of ten models had RMSD values lower (better) than
that of the homology model with respect to all Ca atoms,
and three models had lower RMSDs for the binding site
heavy atoms.
In order to evaluate the docking of compounds to the
models, the ligand was removed and (S)-cyanopindolol was
re-docked to each stage 4 receptor model in triplicate
(Supplementary Table 1). The lowest RMSD value for the
ligand (0.5 A˚, determined after superposition of receptor
binding pocket residues as described in the ‘‘Methods/
experimental’’ section) was observed for the model that
ranked two in total score and five in binding site score
(Supplementary Table 1, see the ‘‘Methods/experimental’’
section for score definitions). The heavy atoms of the
receptor binding site, as defined by residues within 5 A˚
from the ligand in the crystal structure, had an RMSD of
1.6 A˚ for this model (Fig. 4). The docked ligand repro-
duces the receptor interactions well including all hydrogen
bonds except that between the N329/7.39 oxygen and the
basic nitrogen, and a non-optimal interaction between the
protonated ligand nitrogen and D121/3.32 (residues are
referred to by their position in the sequence followed by the
numbering according to Ballesteros-Weinstein [43]).
However, the N329/7.39 interaction with the b-hydroxyl
group of the ligand is in place. The high total Ca RMSD of
5.5 A˚ for this model is due to incorrect TM1 and TM4
positions, and the lack of a helical kink of TM1 (at residue
L50) which is unique to the A and D chains of the
crystallographic structure of b1AR. Helices TM1 and TM4
are expected to be more arbitrarily positioned as they have
lower sequence conservation to the template which leads to
fewer restraints. In fact, TM1 shows more structural vari-
ability when compared to the other TM helices in deter-
mined GPCR structures [14]. In addition, the incorrect
positions of TM1 and TM4 will not be penalized by the
ligand score and has no direct effect on the binding site
geometry as they are not in direct contact with the ligand.
Four additional models reproduce the correct ligand
binding conformation to 1.4–1.7 A˚ RMSD, showing that
the method generates several models that are relevant for
interpretation of ligand recognition. This is a clear
improvement over the RMSD results of the corresponding
starting homology model, which were 3.0, 6.5 and 7.1 A˚
(Supplementary Table 1). Additional information on ligand
binding, e.g. mutation data pointing to critical interactions,
should be used to select the preferred solution among the
top ranked candidates. The low RMSDs for the receptor
and ligand, and good representation of the essential
receptor-ligand interactions for b1AR demonstrate the
(a)
(b)
Fig. 3 Distance restraints between the ligand and receptor place the
ligand near the binding pocket and promote the correct length-wise
orientation during the geometry optimization. a) Three loose distance
restraints roughly orient (S)-cyanopindolol in the b1AR model
binding pocket. Atoms were chosen to minimize bias with regards
to the exact orientation. Hence, Ca atoms of S211/5.42 and S215/5.46
allow either or both side chain or backbone oxygens to form hydrogen
bonds. b) Three distance restraints roughly orient (R)-NPA in the D2
receptor, in analogy to those in panel a. Two restraints include a-
carbons of serine residues in TM5 to carbon C11 in the ligand to
allow any of the main-chain and side chain oxygen atoms to hydrogen
bond to either or both catechol oxygens
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ability of the structure prediction method to generate rel-
evant structure models of monoaminergic receptors using
bovine rhodopsin as template.
Generation of the human dopamine D2 receptor model
The helix docking protocol was also applied to the human
D2R. The starting structure was a homology model for the
helical regions based on the same crystal structure of
bovine rhodopsin bound to the inverse agonist cis-retinal
(PDB id 1u19 [5]) as was used for b1AR. The sequence
identity for the selected region is 25 % (Supplementary
Fig. 3). Tethers were set to the a-carbons of the homology
model for residues that are conserved between the model
and the template. The average number of restraints per
helix is 7, or broken down per helix: 3 (TM1), 10 (TM2), 6
(TM3), 5 (TM4), 10 (TM5), 11 (TM6) and 4 (TM7).
In the helix docking procedure, the D2R-selective full
agonist (R)-N-propylapomorphine ((R)-NPA) was included
to bias the simulation towards the agonist-bound state.
Three loose distance restraints were applied to roughly
orient the ligand in the binding pocket with the protonated
amine near D114/3.32 and the catechol ring near S192/
5.42 and S197/5.46, based on experimental data (reviewed in
[44]) (Fig. 3). Although either one or both ligand catechol
oxygen atoms participate in hydrogen bonding to S193/5.42
and S197/5.46 side chain hydroxyl groups in TM5 [45] (or
main chain carbonyl oxygen atoms), the restraints were set to
carbon atom C11 (Fig. 3) in order to reduce the structural
bias and to improve conformational sampling.
Experimentally determined ligand-receptor interactions
were included in the ligand scoring scheme: Electrostatic
and hydrogen bonding energies were evaluated for the salt
bridge between the protonated amine and the aspartic acid
residues in TM3, and for interactions between serine resi-
dues in TM5 and heteroatoms of the ligand (see the
‘‘Methods/experimental’’ section for details, and Ref. [44]
for a review of the interactions). Complex models that did
not contain a hydrogen bond-stabilized salt bridge were
excluded. It has also been proposed that aromatic interac-
tions between F390/6.52 and the catechol moiety are
important for agonist binding (see e.g. Refs. [46, 47] and
references therein). Since aromatic edge-to-face p-inter-
action energies (reviewed by Waters [48]) are difficult to
evaluate using molecular mechanics methods, we verified
instead that aromatic groups were in contact by (1) calcu-
lating the van der Waals intermolecular interaction energy
between aromatic atoms of F390/6.52 and the ligand
and (2) discarding solutions with energies higher than
-0.3 kcal/mol. With the chosen threshold value, the results
correlate well with the results from manual inspection of
the complexes.
A total of 472 models were generated at stage 1,
whereof 38 passed the first selection filter and nine the
second filter. Despite the use of tethers during the initial
steps, the Ca RMSD was 3–12 A˚ demonstrating the wider
sampling of conformational space. Since the overall bundle
geometries were adequate for the nine final models, a more
detailed criterion for selection was needed that focused on
the properties of the binding pocket. Binding data is
available for a number of D2R ligands (Supplementary
Table 2), which allows the docking and scoring of com-
pounds to define a second model selection criterion, as
described below. It is clear that GPCRs are dynamic and
probably bind structurally diverse ligands by adopting
different conformations [49]. We previously studied ago-
nist binding to D2R [36, 40], and in the present study we
therefore focused on full agonists and inactive compounds.
Selection of dopamine D2 receptor ligands
In virtual ligand screening, docking of a compound library
to a receptor structure model is typically carried out to rank
compounds for their propensity of binding to the receptor.
We assumed that an opposite approach is also valid: By
docking of a library of compounds containing both binding
and non-binding compounds and measuring their geometric
fit to several receptor models, the models can be ranked for
their ligand binding predictive ability. We therefore
selected compounds from the literature with known affinity
and intrinsic activity for the D2R.
The series of compounds used in this study belong
to different structural classes comprising the basic dopa-
mine skeleton in their structure, such as aminotetralins,
phenethylamines, apomorphines, and benzoquinolines.
The ligands were selected on criteria related to their intrin-
sic activity, selectivity, conformational flexibility and
Fig. 4 Structural superposition of the binding site residues of the
b1AR X-ray structure (white ribbon and carbon atoms) and the model
that best reproduces the bound ligand conformation (colored ribbon
and green carbons) viewed from the extracellular side. This region of
the predicted model matches well that of the crystal structure, and all
receptor—ligand hydrogen bonds are reproduced except that between
the carbonyl oxygen of N329/7.39 and the basic nitrogen
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stereochemistry (Fig. 5 and Supplementary Table 2). Suf-
ficiently rigid and selective full agonists at the D2R have
been chosen in the modeling together with structurally
related inactive compounds found in the literature. Inactive
analogs are represented by compounds which do not show
any or only weak effects, i.e. inverse agonists, antagonists
or low intrinsic partial agonists.
The final set contains 29 compounds (Fig. 5 and Sup-
plementary Table 2). A full account for most compounds in
the set is described elsewhere [40]. Basic nitrogen atoms
were protonated before docking. The stereochemistry of
protonated tertiary amine is important in the protein com-
plex model and thus both ‘‘N-enantiomers’’ were included,
resulting in a total of 43 compounds in the docking set.
Ranking of receptor models by D2 ligand docking
performance
The set of compounds was docked to all nine generated
receptor models using torsion space Monte Carlo optimi-
zation to potential (grid) maps representing van der Waals,
electrostatic, hydrogen bonding and hydrophobic interac-
tions that substitute for the receptor, as implemented as the
standard protocol in ICM (version 3.4). Several docking
solutions were stored for each ligand (typically 30–40) by
the protocol. The lowest-energy conformation did not
always make the key interactions (see above), so all con-
formations of each compound were evaluated for the key
interactions to identify the candidate docking solution. No
Fig. 5 Structures of full D2 agonists and inactive compounds used for docking to the final, selected D2R model. References and structures used
in the docking to all D2 receptor models are listed in Supplementary Table 2
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energy threshold was defined, meaning that all conforma-
tions were evaluated. The lowest-energy conformation of
each compound that fulfilled the geometric criteria was
stored. Acceptance of a solution required the energy of the
hydrogen bond between the protonated amino group in the
ligand to D114/3.32 to be -0.2 kcal/mol or lower, that of
hydrogen bonds from any ligand atom (typically hydroxyl
groups of the catechol) to S193/5.42 and/or S197/5.46 to be
-0.2 kcal/mol or lower, and the van der Waals interaction
energy between F390/6.52 and aromatic ligand atoms to be
-0.3 kcal/mol or lower. These values were generously
chosen to allow several docked conformations. For each
receptor model, the number of unique agonists that passed
the selection scheme was summed up and used to rank the
receptor models (Supplementary Table 3). The three top
ranked models were further manually assessed based on the
geometry of the key interactions, the shape match between
the binding pocket and the compounds, and the conver-
gence of structurally similar compounds to a common
binding mode. One D2R model was selected for further
analysis. It had the highest number of accepted docked
agonists and ranked third according to receptor score.
Properties of the selected model
The Ca RMSD of the selected D2 model compared to the
initial (homology) model was 5.4 A˚ (Supplementary
Table 3). Exclusion of TM1 from the analysis, which had
clearly different positions in the two models, yielded a Ca
RMSD of 2.4 A˚. Although TM1 shows structural vari-
ability across different GPCR structures, the large devia-
tion observed here is probably an artifact caused by the
random sampling and the few tethers to this helix. Helix
TM1 is not restrained by, nor directly affect, ligand binding
properties, and therefore neither the ligand binding score
nor the final screening selection will penalize TM1 as long
as it retains properties that are membrane protein-like.
Superposition of Ca atoms of TM2–7 (2.4 A˚ RMSD) shows
that the main structural differences is a sideward shift of
the extracellular ends of TM3 and TM4 by 2–3 A˚ and a
corresponding movement in the opposite direction of TM5.
This results in a decrease of the distance between the
midpoint of the D114/3.32 Oc atoms and S193/5.42 Oc
coordinates, from 14 A˚ in the homology model to 9.1 A˚ in
the selected model, which improves the binding pocket
agonist-binding properties (see below). The movements
may be triggered by the distance restraints and scoring of
receptor-ligand interactions that require helices TM3 and
TM5 to move closer, in analogy to the binding of an
agonist [16–18]. If the Ca atoms of TM3–TM5 are refer-
ence points for superposition instead (2.2 A˚ RMSD) the
structural change is a shift of TM2 and TM7 towards TM6
by approximately 3 A˚, causing TM6 to tilt out from the
bundle center on the intracellular side by 2 A˚. The outward
shift of TM6 is an important structural feature of the
activated state of rhodopsin [19–22], the b2AR [17, 18] and
the A2A adenosine receptor [15]. The magnitude of the shift
in the D2R model is modest in comparison to the structures
(2 A˚ vs. 6–11 A˚) since the G-protein was not included in
the model and also due to the presence of tethers to the
inactive state helix packing. Residues I3.40 and F6.44 were
suggested to couple conformational changes of the binding
pocket with TM6 based on the active agonist-bound b2AR
structure [17]. These conformational changes are not
observed in the D2R model, probably due to the inactive-
state conformation of the intracellular part of TM6. The
binding pocket score of the homology model was inferior
relative to that of the selected model. However, the packing
score of the homology model was better than those of the
models generated by the presented method (see the
‘‘Methods/experimental’’ section for details on the score
definitions).
Binding site analysis
For further analysis, a more focused set of compounds was
used (Fig. 5) by removal of compounds that were struc-
turally similar. Also, compounds that contained large
substituents that were expected to interact with the extra-
cellular loop 2 (ECL2) were removed due to the lack of
loops in the receptor model. Docking and evaluation using
the same criteria as above (geometry of key interactions,
shape match and convergence to a common binding mode)
resulted in the correct binding mode for all 11 agonists for
the selected model. The shape of the binding pocket was
calculated using the icmPocketFinder function of ICM that
detects both buried and surface-exposed binding sites [50].
This method is useful for the D2R model since the ECL2,
that closes the pocket in known GPCR structures, is
missing. The volume (458 A˚3) and shape of the binding
pocket matches those of the majority of agonists in this
study, and the selected docking solutions form a tight
cluster (Fig. 6a). The distance from the carboxylate group
of D114/3.32 and the Oc hydroxyl of S193/5.42 is 9.1 A˚,
which is 5.4 A˚ shorter than that of the unrefined rhodopsin-
based homology model. This is in good agreement with the
shorter distance between TM3 and TM5 of the activated
state that has been suggested [19–22] and later confirmed
by structural studies [15, 18]. It also agrees well with the
9.1 A˚ distance in a pharmacophore model for selective D2
agonists, measured from the projected pharmacophoric
features representing the serine hydrogen bond donor/
acceptor to the aspartic acid projected feature [40]. The
corresponding distance in the inverse-agonist bound
structure of the dopamine D3 receptor is 9.9 A˚ [13]. Nine
out of the ten inactive compounds in the set also matched





Fig. 6 a Orthogonal views of
ten D2R-active compounds
docked to the selected D2R
model showing a good match to
the size and shape of binding
pocket (blue surface). Selected
proximal side chains and
ribbons were removed for




region, and ligands therefore
seems to protrude through the
pocket. Selected side chains are
labeled. b Definition of three
regions discussed in the text:
The catechol pocket (red), the
propyl pocket (green) and the
ECL2-proximal pocket (yellow).
Other regions of the receptor
molecular surface are white,
selected side chains are shown
and labeled, and rotigotine is the
representative compound. The
amine proton points towards
D114/3.32 which is near the
viewer. Selected helix numbers
are indicated. c Orthogonal
views of the average atomic
property fields (APFs)
calculated from docked agonists
matching properties of the
receptor model. The receptor is
shown as ribbon and ball-and-
stick models. The surfaces are
isocontours for the property
fields: sp2 hybridized (green),
hydrogen bond donor (cyan)
and acceptor (red) (top panels)
and hydrophobic (green) and
positively charged (blue) (lower
panels). Note the hydrophobic
extension near the positive
charge that matches the propyl
substituents on the basic
nitrogen
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(all but (-)-DHX), suggesting that the selection criteria
and/or the model properties are not sufficient for discrim-
ination between active and inactive compounds in their
current form.
Dopamine D2R ligand recognition
Three sub-pockets are present in the binding site of the
model (Fig. 6b): (1) A catechol-binding region offers
hydrogen bonding interactions to three serine residues in
TM5, and aromatic interactions with F390/6.52 in TM6. In
addition, V115/3.33 in TM3 is in position to form hydro-
phobic contacts with the ligand. These receptor-ligand
interactions are well established in the literature [45–47,
51, 52]. (2) The model has a small hydrophobic pocket near
TM7. Binding studies have shown that a propyl substituent
on the basic amino group is important for D2R selectivity
over the dopamine D1 receptor [53–56]. The basic amine
can carry two aliphatic substituents, but only one of them
can be larger than three carbons or the affinity decreases
[54]. An explanation is suggested by the D2R model: The
hydrophobic pocket near TM7, formed by W386/6.48,
T412/7.39, G415/7.42 and Y416/7.43, corresponds in size
and shape to an n-propyl group. The other substituent
projects in the direction of the loops, which are more
flexible and may accommodate larger groups. (3) A pocket
near the extracellular face of similar size as the catechol-
binding pocket. Its size is not well-defined due to the
absence of ECL2. However, due to the higher variability of
the loop region compared to the helical region, this part is
likely to be more flexible than the membrane-buried parts
and may adapt to a variety of chemical substituents.
In combination with D114/3.32, these three pockets
form a tetrahedral arrangement around the basic amino
group of the ligand (Fig. 6b), which allows the binding
mode of many catechol-containing monoaminergic ligands
to be rationalized. The requirement of a hydrogen bond
between the basic amine and D114/3.32 sets a clear
directional restraint, which leads to a critical dependence of
the stereochemical configuration around the protonated
nitrogen for the fit to the binding pocket. Therefore, only
one of the N-enantiomers was accepted for compounds
with a stereogenic protonated nitrogen and a clear differ-
ence in size of the N-substituents.
In order to generalize the docking results, the properties
of the ligand ensemble were represented by so called atom
property fields (APFs) [57] for the accepted docked solu-
tions of the agonists. The APFs are 3D grid representations
of seven properties that are assigned to each atom:
Hydrophobicity, hydrogen bond acceptor, hydrogen bond
donor, charge, sp2 hybridization, size, and electronegativ-
ity. In contrast to the initial APF study, the APFs reported
here are based on the docked conformations of the ligands
which therefore take receptor interactions into account. As
expected, hydrogen bond donor and positive charge fields
map to the basic amino group, and aromatic fields are
present near TM5, but also near the location of ECL2
(Fig. 6c). The hydrogen bond donor field has an elongated
maximum along the ridge of the catechol rings, adjacent to
serine residues 193/5.42, 194/5.43 and 197/5.46 on TM5.
The hydrogen bond acceptor fields are localized to two
lobes on either side of the rings. The presence of propyl
substituents on the amines is manifested as an elongated
hydrophobic field close to TM7.
As described above, the criterion for the final selection
of one out of the nine receptor models is based on the fit of
a set of compounds to the ligand binding site. Whereas our
aim was that the agonist-biased optimization should favor
the active state of the receptor [58], the structural adapta-
tion is not necessarily propagated throughout the whole
structure with the current settings. For example, the out-
ward movements of the parts of TM5 and TM6 close to the
intracellular side is not of the same magnitude as those of
active-state receptors [15, 18]. Although these two states
may be partly uncoupled, as shown in the crystal structure
of the b2AR T4L chimera bound to an inverse agonist
while the cytoplasmic end is in the active state [59], tethers
to residues in the intracellular region of the receptor may
be removed in future work, or set to the corresponding
residues of a model in the G-protein interacting state [7].
Conclusions
During the last few years, progress in 3D structure deter-
mination of GPCRs has enabled analysis of ligand recog-
nition by their receptors in different conformational states.
The structures of 15 receptors are known at present [14], all
belonging to family A, but so far only three agonist-bound
active-state structures have been reported (b2AR [17, 18]
and A2A adenosine receptor [15]). Homology models and
ab initio methods have been used to model other receptors,
and whereas homology modeling tends to be limited to
similar backbone geometries, ab initio methods are gen-
erally computationally expensive. Therefore we have
combined the two strategies into a semi-empirical method
that re-models the helical bundle of a 7TM homology
model by Monte Carlo optimization, guided by a ligand
and by restraints derived from experimental data, allowing
for larger backbone variation while keeping a bias towards
the template structure.
A wide conformational space was sampled, as demon-
strated by the application of the method to the b1AR and
D2R receptors. The automatic docking of agonists to the
selected D2R receptor model converged to a common
binding mode for several compounds, and alternative
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binding modes were selected manually from the docking
conformational stacks to yield a well-defined model for
agonist binding. The structural features of docked ligands
were interpreted using APF, and they correlated well with
experimental data. The binding site has been biased
towards the agonist-bound state by the use of constraints
based on receptor-agonist key interactions. However, these
conformational changes were not propagated to the inac-
tive state R132/3.50–E368/6.30 ionic lock on the intracel-
lular side, probably due to the constraints to conserved
residues of the homology model. Therefore, the analysis is
restricted to the ligand-binding site in the current form of
the method. It is however possible to bias the structure
optimization to several structure templates depending on
the desired properties—e.g. using the binding pockets of
monoaminergic receptors or the intracellular part of
G-protein peptide-bound structure models [7, 18].
This type of semi-empirical approach has a potential for
modeling of receptor targets for which a structural template
with sufficient sequence homology or the correct confor-
mational state is unavailable, but for which sufficient
empirical information is accessible to guide the modeling.
Methods/experimental
General
Default ICM energy terms and parameters were used for
energy evaluations [60]. The maximal van der Waals
interaction energy in the first stage of structure optimiza-
tion was limited to 2.0 kcal/mol. A distance-dependent
dielectric constant of 4 was used. Template structures were
converted to ideal covalent geometry prior to homology
model building to conform with the ICM internal coordi-
nate force field [60]. Homology models were built using
standard techniques implemented in ICM.
Since the focus of this study was ligand recognition, the
torsion variables of the ligand binding region were sampled
more often in the Monte Carlo protocol. Variables of the
ligand (torsions and positional variables) were sampled
twice as often as those of the binding pocket (defined as
residues within 7 A˚ from the ligand in this context), five
times more often than helix positional variables and 50
times more often than the remaining protein residues. The
binding pocket residues were re-defined regularly during
the optimization to account for structural changes.
All calculations were performed on a dual Intel Xeon
workstation running Linux. The generation of ten final
models (stage 4) from a single homology model typically
required 4–5 days on this single computer, and the docking
of ligands and automatic evaluation required 1 day. Cov-
ering the corresponding conformational space using
molecular dynamics simulations would require signifi-
cantly larger computational resources.
Protein/ligand complex scoring
The qualities of the generated complex models need to be
assessed during and after the docking part. We therefore
developed a series of functions that score the protein and
ligand geometries and energies. Protein-related scoring
terms are aimed to evaluate helical membrane protein
structures in general and are related to a) the total protein
molecular surface area and volume, the distance between
helix centra, the number and volume of internal cavities,
and b) the tilt of helices relative to the overall bundle
orientation, the offset of helix centra from the mid-plane of
the bundle (parallel to the membrane), the distances
between helix ends relative to loop lengths, and the dis-
tance between the polar residues that anchor distal parts of
the ligand. The weighted sum of terms in a) is referred to as
the protein packing score, whereas that of b) is the protein
orientation score. The ligand score is target-specific and
depends on the chemical properties of the compound and
its interactions with the receptor. The three scores are
weighted and summed into a total score for the complex.
The development of each term and determination of weight
factors were based on their application to a selected set of
determined membrane protein structures and decoy 7TM
models where helical orientations were partially random-
ized. Since it was not known a priori which functions
would give meaningful measures of quality, we allowed
overlapping functions be included.
Packing
The terms that correlate with packing include the follow-
ing: Total molecular volume and area—tightly packed
complexes tend to have smaller volumes and areas. Num-
ber and volume of pockets—badly packed cores contain
buried pockets that were predicted by ICM’s pocket finder.
Pockets located on the surface of the receptor are also
predicted by the method but are not related to packing
defects, which leads to noise in this term. Helix center
distance—The distances between the geometric centers of
each helix and the bundle centre are summed. An offset of
a helix along its helical axis relative to the bundle will
increase this term, and it is generally a good measure of
packing if residue ranges are properly chosen.
Orientation
Hydrophilic surface Hydrophilic residue side chains are in
general in contact with other protein residues and hidden
from the lipid surrounding. The exposed area of
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hydrophilic residues was calculated for residues in helix
conformation considering the solvent exposed area of (1)
those charged and polar groups that were at least 25 %
surface-exposed relative to their standard exposed area in a
Gly-X-Gly tripeptide [60] and (2) all charged and polar
residues including also those of small surface-exposed
area. Only the most membrane-embedded mid-third section
of the bundle was considered. Tilt Strongly tilted helices
are rare in membrane proteins, with the exception of
shorter segments near the membrane surface. Helix seg-
ments that were tilted more than 50  compared to the
bundle axis were penalized by an amount proportional to
the tilt. Helices are assigned prior to this calculation, based
on the ICM assignment (a modification of the DSSP [61]
algorithm). This is followed by a more conservative re-
evaluation by breaking helices into segments at helical
kinks based on the distance between carbonyl oxygens in
the backbone. The overall orientation vector of the bundle
was determined by the sum of the individual helix vectors,
weighted by the number of residues in each helix. All
helical vectors were clustered prior to the overall bundle
axis determination, and up to 10 % of the helices that were
not in the main cluster were neglected to avoid the con-
tribution from helices that deviated from the main bundle
vector. Elevation Elevation is the calculated distance offset
of helix centers from the membrane mid-plane and should
be near zero if helix regions are accurately modeled. Loops
The distance between helix termini is not explicitly limited
during the docking since loops are not included in models.
Preliminary attempts to use distance restraints as replace-
ments for loops were not satisfactory, instead we intro-
duced a scoring term based on the difference between the
distance between the helical end residues and the expected
maximal length of the loop (estimated using 3.2 A˚ per
residue). Distance between ligand anchor residues A flat-
bottom quadratic function was used to score the distance
between key interacting residues that anchor distal parts of
the ligands. The target distance was estimated from ligand
geometry, as described for each case above.
Ligand
The ligand score is calculated from receptor-ligand inter-
action energies and is defined similarly for each complex,
see below.
Ligand docking to sets of receptor models
For the ligand docking to sets of receptor models, docking
parameters were set up for one protein–ligand complex
model and used for all other models, except for the exact
selection of receptor atoms. The atom selection was made
using a 10 9 10 9 10 A˚3 box with defined coordinates for
one model, and other receptor models were superimposed
with the ICM ‘‘align’’ sequence/structure alignment tool
which aligns those parts of the 3D model that are conserved
in sequence. This means that single helices that differ in
orientation relative to the folded core will not affect the
structural alignment and binding site selection.
Turkey b1AR test case
The structure prediction method was developed using the
turkey b1AR as target, and the bovine rhodopsin crystal
structure (pdb entry 1u19) [5] as the template. The helical
sequence regions W40-S68, L75-V103, G110-A142, R155-
I177, R205-E233, H286, V314, D322-Y343 were used to
build a homology model using ICM. The inverse agonist
(S)-cyanopindolol was generated from 2D coordinates
using ICM and added to the receptor model. In the scoring
evaluation, the non-penalized distance from the average
coordinate of the Od atoms of D121/3.32 to the average
coordinate of the Oc atoms of S211/5.42 and S215/5.46
was set to 9.5 ± 1.5 A˚. The corresponding distance is
10.8 A˚ in the crystal structure. The ligand score was the
weighted sum of the following terms: Hydrogen bond
energy between the ligand and serine residues S211/5.42
and S215/5.46; electrostatic and hydrogen bond energies
between the ligand and the side chain atoms of D121/3.32;
distance restraint energies from two heavy atoms of the
ligand and three receptor atoms (Fig. 3a), and van der
Waals interactions between ligand aromatic atoms and
F06/6.51,F307/6.52 that substitutes for aromatic face-to-
edge p–p interactions (see ‘‘Results and discussion’’). Too
large conformational variation was observed for TM7
which was due to the lack of restraints at its N-terminal
half. Only four residues at the extreme C-terminus are
conserved in the 22 residue helix. Therefore one extra
restraint from the model N-terminus to the template was
defined for the N329/7.39 Ca atom, yielding a total number
of restraints of 5, 7, 9, 3, 7, 7 and 5 for TM1-TM7,
respectively. The 19 residues that were within 5 A˚ from the
ligand in the crystal structure were defined as binding site
residues. Receptor and ligand RMSDs for each model were
calculated after superposition of the binding site residues.
Dopamine D2 modeling
The modeled helical regions were Y34-E62, T67-V97,
F102-T134, K149-G173, A185-K211, E368-D400, P405-
I425. In the scoring evaluation, the non-penalized distance
from the average coordinate of the Od atoms of D114/3.32
to the average coordinate of the Oc atoms of S193/5.42 and
S197/5.46 was set to 12 ± 2 A˚ estimated from the corre-
sponding distance (15 A˚) in the homology model and
considering the longest distance between the catechol
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oxygens and the nitrogen of (R)-NPA (8 A˚). The ligand
score was the weighted sum of the following terms:
Hydrogen bond energy between the ligand and serine res-
idues S193/5.42 and S197/5.46; electrostatic and hydrogen
bond energies between the ligand and the side chain atoms
of D114/3.32; distance restraint energies from two heavy
atoms of the ligand and three receptor atoms (Fig. 3b), and
van der Waals interactions between ligand aromatic atoms
and F389/6.51,F390/6.52 that substitutes for aromatic face-
to-edge p-p interactions (see ‘‘Results and discussion’’).
The distribution of Ca RMSD from all models to the
template was 3.5–5 A˚ for about 90 % of the solutions, and
above 5 A˚ for the remaining fraction.
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